克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品
克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.
TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
- Registration number
- 1106605835
- Chinese name
- 克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品
- English name
- CROESUS PTGC UC-Ⅱ NO.667 EX SOFTGEL
- Type
- Imported tablets and capsules
- Published status
- Status not provided in this export; the validity date is shown separately
- Licence holder
- 雄美有限公司
- Registration date
- 2021-07-07
- Published validity end
- 2026-07-07
The foreign register category does not determine the regulatory category of the product in France.
French and European references for recognised ingredients
No point flagged by the rules applied to recognised ingredients.
Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.
Published composition
| Published ingredient | Published text and quantity | Identified nutrient or substance |
|---|---|---|
| MSM (METHYLSULFONYL METHANE) | MSM (METHYLSULFONYL METHANE) | Not identified |
| GLUCOSAMINE HCL | GLUCOSAMINE HCL | Not identified |
| SHEA BUTTER FRUIT | SHEA BUTTER FRUIT | Not identified |
| SHARK CARTILAGE POWDER | SHARK CARTILAGE POWDER | Not identified |
| CHICKEN COLLAGEN | CHICKEN COLLAGEN | Collagène de poulet |
| CALCIUM AMINO ACID CHELATE | CALCIUM AMINO ACID CHELATE | Calcium |
| PILOSE ANTLER | PILOSE ANTLER | Not identified |
| TURTLE POWDER | TURTLE POWDER | Not identified |
| YUCCA BREVIFOLIA ENGELMAN ROOT EXTRACT | YUCCA BREVIFOLIA ENGELMAN ROOT EXTRACT | Not identified |
| CAT'S CLAW ROOT EXTRACT | CAT'S CLAW ROOT EXTRACT | Not identified |
| BROMELAIN | BROMELAIN | Not identified |
| SALMON NASAL CARTILAGE | SALMON NASAL CARTILAGE | Not identified |
| TURMERIC ROOT EXTRACT | TURMERIC ROOT EXTRACT | Not identified |
| DL-ALPHA TOCOPHERYL ACETATE | DL-ALPHA TOCOPHERYL ACETATE | Vitamine E |
| THIAMINE MONONITRATE | THIAMINE MONONITRATE | Vitamine B1 (thiamine) |
| RIBOFLAVIN | RIBOFLAVIN | Vitamine B2 (riboflavine) |
| CYANOCOBALAMIN | CYANOCOBALAMIN | Vitamine B12 |
| VITAMIN D3 (CHOLECALCIFEROL) | VITAMIN D3 (CHOLECALCIFEROL) | Vitamine D |
| GELATIN | GELATIN | Not identified |
| GLYCEROL | GLYCEROL | Glycérol |
| BEESWAX | BEESWAX | Not identified |
| WATER | WATER | Not identified |
| SUNSET YELLOW FCF | SUNSET YELLOW FCF | Not identified |
| SORBIC ACID | SORBIC ACID | Not identified |
The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.
Original register data
View published fields and their variants
- Product name
- 克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品
- Active ingredients
- MSM (METHYLSULFONYL METHANE);;GLUCOSAMINE HCL;;SHEA BUTTER FRUIT;;SHARK CARTILAGE POWDER;;CHICKEN COLLAGEN;;CALCIUM AMINO ACID CHELATE;;PILOSE ANTLER;;TURTLE POWDER;;YUCCA BREVIFOLIA ENGELMAN ROOT EXTRACT;;CAT'S CLAW ROOT EXTRACT;;BROMELAIN;;SALMON NASAL CARTILAGE;;TURMERIC ROOT EXTRACT;;DL-ALPHA TOCOPHERYL ACETATE;;THIAMINE MONONITRATE;;RIBOFLAVIN;;CYANOCOBALAMIN;;VITAMIN D3 (CHOLECALCIFEROL);;GELATIN;;GLYCEROL;;BEESWAX;;WATER;;SUNSET YELLOW FCF;;SORBIC ACID;;
- Valid until
- 1150707
- Registration number
- 1106605835
- Licence holder
- 雄美有限公司
- Registration date
- 1100707
- Published reference
- DHC0B066058357
- Published English name
- CROESUS PTGC UC-Ⅱ NO.667 EX SOFTGEL
Official source
View the official register, number 1106605835
Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0
Open Government Data License, version 1.0
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- VITAMIN D3 (CHOLECALCIFEROL)
Read the warning, when it applies and the studies cited
VITAMIN D (>1,000 - 2,500 IU)
Route of administration: Oral
Cautions and warnings
Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.
Applies to products containing vitamin K2.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products containing zinc sourced from picolinate.
Do not use if you are pregnant or breastfeeding (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Known adverse reactions
Condition of application: All products.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).
2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing more than 350 mg of magnesium per day.
When using this product you may experience diarrhea (NNHPD 2026).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.